Solara Active Pharma Sciences rose 3.10% to Rs 1,698.80 after Shivanand Shankar Mankekar bought 8.70 lakh equity shares or 2.42% stake at Rs 1,552.05 per share of the company via bulk deal on NSE on Monday (10 May 2021).
Pronomz Ventures sold 8.70 lakh equity shares of Solara Active Pharma at Rs 1,552.05 per share via bulk deal on NSE on Monday.
Professor Shivanand Shankar Mankekar is a high net-worth investor (HNI) and a former full-time professor at Mumbai s Jamnalal Bajaj Institute of Management Studies.
As per the bulk deal data on the BSE, Aditya Birla Sun Life Flexi Cap Fund bought 3,90,000 shares (1.09%), Aditya Birla Sun Life Mutual Fund bought 1,94,000 shares (0.54%) and Classic Opportunities Fund ULIF 033 16 12 09 CLAOPPFND 107 bought 2,57,823 shares (0.72%) in Solara Active Pharma at Rs 1,552.05 per share on Monday (10 May 2021).
Domestic indices saw profit taking after rising for four consecutive trading sessions on Tuesday. The Nifty 50 index ended near the 14,850 level. Metal, private banks corrected while media and PSU banks shares advanced.
As per the provisional closing data, the barometer index, the S&P BSE Sensex, declined 340.6 points or 0.69% to 49,161.36. The Nifty 50 index fell 91.60 points or 0.61% at 14,850.10.
The broader market outperformed the benchmark indices. The S&P BSE Mid-Cap index rose 0.6% while the S&P BSE Small-Cap index added 0.8%.
Buyers outpaced sellers. On the BSE, 1,845 shares rose and 1,198 shares fell. A total of 196 shares were unchanged.
Investors locked profits after the Sensex rose 2.59% and the Nifty climbed 3.08% in the past four sessions.